Cutler Group LP Bridge Bio Pharma, Inc. Call Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$16.89 - $35.01 $16,890 - $35,010	1,000 New	1,000 $0
Q1 2023 May 01, 2023	BUY	$7.17 - $18.55 $52,341 - $135,415	7,300 New	7,300 $13,000
Q3 2022 Oct 25, 2022	SELL	$7.94 - $12.36 $58,756 - $91,464	-7,400 Reduced 68.52%	3,400 $6,000
Q2 2022 Aug 04, 2022	SELL	$5.21 - $12.14 $104,721 - $244,014	-20,100 Reduced 65.05%	10,800 $12,000
Q1 2022 Apr 14, 2022	SELL	$7.34 - $17.16 $455,814 - $1.07 Million	-62,100 Reduced 66.77%	30,900 $20,000

Q4 2021 Jan 18, 2022	BUY	$11.38 - $53.41 $919,504 - $4.32 Million	80,800 Added 662.3%	93,000 $126,000
Q3 2021 Oct 26, 2021	BUY	$46.87 - $64.24 $51,557 - $70,664	1,100 Added 9.91%	12,200 $19,000
Q2 2021 Jul 19, 2021	BUY	$46.47 - $63.93 $204,468 - $281,292	4,400 Added 65.67%	11,100 $16,000
Q1 2021 Apr 26, 2021	BUY	$55.47 - $72.35 $316,179 - $412,394	5,700 Added 570.0%	6,700 $10,000
Q3 2020 Oct 27, 2020	SELL	$27.2 - $42.19 $786,080 - $1.22 Million	-28,900 Reduced 96.66%	1,000 $2,000
Q2 2020 Jul 22, 2020	BUY	$22.22 - $35.69 $408,848 - $656,696	18,400 Added 160.0%	29,900 $66,000
Q1 2020 May 07, 2020	BUY	$16.11 - $36.23 $185,265 - $416,644	11,500 New	11,500 $42,000

285

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.88B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.